1.
Pozo Sanhueza P, Mondaca Muñoz JP, Diaz Aguirre PA, Escalona Arranz JC. Applications and limitations of CRISPR-Cas9 in breast cancer therapy: A structured evidence review (2018–2026). Orange. J. [Internet]. 2026 Oct. 5 [cited 2026 Nov. 20];8(14):36-51. Available from: https://orangejournal.info/index.php/orange/article/view/94